Professor Oliver Fitzgerald is based at the University College Dublin and has a major interest in clinical and translational research in psoriatic arthritis (PsA). His more recent studies have explored genetic factors and biomarker development. Oliver has been involved with Group for Research and Assessment in Psoriasis and Psoriatic Arthritis (GRAPPA) for many years and became co-president in July 2021. He has been advocating for grant application opportunities addressing critical unmet needs in PsA for some time, and this has culminated in the award of the first significant, joint EU/industry-funded Innovative Medicines Initiative (IMI) grant in PsA, the HIPPOCRATES consortium.
IPC 2023 Think Tank Meeting Report Published in JID Innovations.
Read key highlights from the 2023 International Psoriasis Council (IPC) Think Tank Meeting, summarizing the evolving…